Executive Order Category Rationale

Justification

This executive order is fundamentally focused on prescription drug pricing and access within federal healthcare programs, particularly Medicare and Medicaid. The order's primary subject matter is pharmaceutical costs and healthcare affordability for American patients, specifically targeting drug pricing mechanisms, pharmacy benefit managers, generic drug approval processes, and drug importation policies. While the order does involve some regulatory reforms and government program modifications, its core purpose is to address a public health and healthcare access issue—ensuring Americans can afford life-saving medications through various healthcare policy interventions including capping insulin costs, promoting generic competition, and reforming the Medicare Drug Price Negotiation Program. The order's implementation would primarily impact healthcare delivery, patient access to medications, and the structure of federal health programs rather than general government operations.

Secondary relevant categories

• Regulatory Reform & Oversight
• Economic & Fiscal Policy